4//SEC Filing
Slilaty Steve N. 4
Accession 0001683168-22-001185
CIK 0001402328other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 1:07 PM ET
Size
4.9 KB
Accession
0001683168-22-001185
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Disposition to Issuer
Series B Preferred Stock
2022-02-18$0.10/sh−990,000$99,000→ 10,000 total
Footnotes (1)
- [F1]Dr. Slilaty returned 990,000 shares of Series B Preferred Stock to the Issuer for a redemption price equal to the stated value of $0.10 per share.
Documents
Issuer
Sunshine Biopharma, Inc
CIK 0001402328
Entity typeother
Related Parties
1- filerCIK 0001474684
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 1:07 PM ET
- Size
- 4.9 KB